Technology News and Research

RSS

Myoderm expands its portfolio to include drug procurement, management and distribution services

Myoderm, a leading global pharmaceutical supplier of comparator drugs for clinical research and clinical trials, has expanded its portfolio to include Distribution Management Services. This new capability provides their clients with an efficient solution for sourcing, managing, and distributing off-the-shelf, commercial drugs used in clinical trials.

25 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application directed to the use of its disposable hand piece for fluid administration.

25 Aug 2009

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

Ecology Coatings, Inc., a leader in the discovery and development of nanotechnology-enabled, ultraviolet-curable advanced coatings, today announced that it has signed a collaboration agreement with a major tobacco company for the application of its technology for producing "fire standard compliant" (FSC) cigarettes.

25 Aug 2009

Caretech Solutions to implement CareWorks content management system for Blessing Health System

CareTech Solutions, Inc. (www.caretechsolutions.com), an information technology (IT) and Web products and services provider for hospitals and health systems nationwide, announced today it has signed an agreement to provide Web services to Blessing Health System (www.blessinghospital.org), based in Quincy, Ill.

25 Aug 2009

Phase I/II trial of Amphinex uses photochemical internalisation approach

PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.

25 Aug 2009

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer.

24 Aug 2009

Patients suffering from functional and degenerative mitral regurgitation treated using the MitraClip system

Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, today announced treatment of the first group of patients with the MitraClip(R) system at the Karolinska University Hospital in Solna, Stockholm, Sweden.

24 Aug 2009

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

A team of researchers and information technology specialists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center has won the caBIG- 2009 Deployment Award from the National Cancer Institute (NCI).

24 Aug 2009

Advanced Instruments' next-generation website facilitates easy retrieval of product and application information

Advanced Instruments has introduced a next-generation Web site that dramatically enhances the customer's online business experience when purchasing osmometers, cryoscopes, and microbiological laboratory instruments.

24 Aug 2009

Boston Software Systems to host a webinar on uses and advantages of hospital workflow automation

Boston Software Systems, the leader in workflow automation technology to the healthcare market, today announced Thom Blackwell, product manager, will host a Webinar with several McKesson users on the uses and advantages of workflow automation on August 27. The Webinar is titled “Harness the Benefits of Automation in the McKesson Environment.”

24 Aug 2009

VeriMed Health Link re-launched by VeriChip Corporation

VeriChip Corporation("VeriChip" or the "Company"), a provider of radio frequency identification (RFID) systems for healthcare and patient-related needs, announced today that it is re-launching its VeriMed Health Link electronic health records system.

24 Aug 2009

The Estate Vault to open a subsidiary in Australia for delivering portable health management solutions

The Estate Vault, Inc.,a leading provider of comprehensive electronic repository services for consolidating and protecting, medical, personal financial, and legal records, announced today that in response to the May 2009 announcement from the Australian National Health & Hospitals Reform Commission, that it will open a wholly owned subsidiary in Australia.

24 Aug 2009

ZoomMed announces registration of American subsidiary ZoomMedUSA

ZoomMed Inc., creator of the ZRx Prescriber, announces that it has registered an American subsidiary under the name ZoomMedUSA Inc. in order to export the ZRx Prescriber to the United States.

24 Aug 2009

CDEX's ID2 Meth Scanner to help combat the growing problem of methamphetamine use

CDEX Inc. announces completion of development-phase testing of a new generation Meth Scanner™ that embodies cell-phone technology and multi-filter applications. The new generation Scanner will have a cell-phone-interactive readout that increases functionality to provide more options for the law enforcement community in its battle against methamphetamine use. In addition, the technological advancements of multi-filter integration will provide greater sensitivity and a platform for multi-drug applications for the Scanner.

24 Aug 2009

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Santaris Pharma A/S, a privately-held biopharmaceutical company focused on developing RNA-based drugs targeted to disease-related mRNAs and microRNAs, today announced a multi-year worldwide strategic alliance with Shire plc to discover and develop new RNA-based medicines to treat rare genetic disorders.

24 Aug 2009

Complete Genomics raises $45 million in private equity financing

Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors — Essex Woodlands Health Ventures and OrbiMed Advisors, LLC.

24 Aug 2009

Bioelectronics to sponsor clinical study comparing the effects of ActiPatch to Tylenol for the treatment of muscle pain and soreness

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it will sponsor a clinical study comparing the effects of ActiPatch® Therapy to Tylenol® for the treatment of muscle pain and soreness.

24 Aug 2009

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

As thousands of people plan getaways for the fall and winter travel seasons, easy access to healthcare is a concern for many travelers with chronic health conditions who require life-sustaining treatments. Twenty-six million Americans suffer from chronic kidney disease, and more than 355,000 of them require dialysis every few days to stay alive.

24 Aug 2009

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease). The company expects to begin Phase I clinical studies in 2010.

24 Aug 2009

Technology News and Research

Myoderm expands its portfolio to include drug procurement, management and distribution services

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Milestone Scientific receives Notice of Allowance to use disposable hand piece for fluid administration

Ecology Coatings collaborates with a tobacco company for producing fire standard compliant cigarettes

Caretech Solutions to implement CareWorks content management system for Blessing Health System

Phase I/II trial of Amphinex uses photochemical internalisation approach

Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin

Patients suffering from functional and degenerative mitral regurgitation treated using the MitraClip system

UAB researchers and information technology specialists win the caBIG- 2009 Deployment Award

Advanced Instruments' next-generation website facilitates easy retrieval of product and application information

Boston Software Systems to host a webinar on uses and advantages of hospital workflow automation

VeriMed Health Link re-launched by VeriChip Corporation

The Estate Vault to open a subsidiary in Australia for delivering portable health management solutions

ZoomMed announces registration of American subsidiary ZoomMedUSA

CDEX's ID2 Meth Scanner to help combat the growing problem of methamphetamine use

Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders

Complete Genomics raises $45 million in private equity financing

Bioelectronics to sponsor clinical study comparing the effects of ActiPatch to Tylenol for the treatment of muscle pain and soreness

Fresenius Medical Care's Patient Travel Service to provide free dialysis scheduling assistance to travelling patients

Israeli government and a private investment fund Brainstorm Cell Therapeutics to complete pre-clinical studies in ALS

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News